Parnax Lab Share Price

CMP as on27-Nov-20 15:40

₹ 29.20
0.65 2.28%

Open

₹ 28.50

Turnover (lac)

Prev. Close

₹ 28.55

Day's Vol (shares)

₹ 1,851

Day's Range

₹ 28.40
₹ 29.40

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 03-Nov-2020 - -
PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2020 ,inter alia, to consider and approve standalone and Consolidated Un-audited IND- AS Compliant Financial Results along with Limited Review Report for the quarter and half year ended 30th September 2020 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Any other business with permission of chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director. The approved results will be sent to you after conclusion of Board meeting. Kindly acknowledge the receipt of the same Dear Sir, Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) we wish to inform you that in the meeting of the Board of Directors of the Company held on Thursday,12th November 2020 at its Registered Office, the Board inter alia has transacted the following business: 1. Approval of Un-Audited Standalone & Consolidated Financial Results as submitted by statutory auditor of the Company for the quarter and half year ended 30th September, 2020. 2. Considered and took note of Limited Review Report for the quarter and half year ended September 30, 2020. The Meeting was commenced at 4.00 p.m. and concluded at 7.00 p.m. Kindly take the same on your record. Thanking You, (As per BSE Announcement Dated on 12/11/2020)
Board Meeting - 07-Sep-2020 - -
Quarterly Results PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/09/2020 ,inter alia, to consider and approve Standalone and Consolidated Un-audited IND-AS compliant Financial Results along with Limited Review Report for the quarter ended 30th June, 2020 pursuant to regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director. The approved results will be sent to you after conclusion of Board meeting. Kindly acknowledge the receipt of the same. PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/09/2020 ,inter alia, to consider and approve Standalone and Consolidated Un-audited IND-AS compliant Financial Results along with Limited Review Report for the quarter ended 30th June, 2020 pursuant to regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director. The approved results will be sent to you after conclusion of Board meeting. Kindly acknowledge the receipt of the same. PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/09/2020 ,inter alia, to consider and approve Standalone and Consolidated Un-audited IND-AS compliant Financial Results along with Limited Review Report for the quarter ended 30th June, 2020 pursuant to regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director. The approved results will be sent to you after conclusion of Board meeting. Kindly acknowledge the receipt of the same. (As Per BSE Announcement Dated on 04/09/2020) Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) we wish to inform you that in the meeting of the Board of Directors of the Company held on Tuesday,15th September, 2020 at its Registered Office, the Board inter alia has transacted the following business: 1. Approval of Un-Audited Standalone & Consolidated Financial Results as submitted by statutory auditor of the Company for the quarter ended 30th June, 2020. 2. Considered and took note of Limited Review Report for the quarter ended 30th June, 2020. The Meeting was commenced at 4.00 p.m. and concluded at 6.00 p.m. Kindly take the same on your record. (As per BSE Announcement Dated on 15/9/2020)
Board Meeting - 25-Aug-2020 - -
Dear Sir, Pursuant to the provisions of Regulation 30 the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 (Listing Regulations), we would like to inform you that the meeting of Board of Directors of the Company held on August 25,2020 to inter-alia considered and approved the following: 1. Approval of Notice & Date of 38th Annual General Meeting to be held on 30th September, 2020 through Video Conferencing (VC)/ other audio -visual means(OVAM). The Meeting Commenced at 4.00 P.M. and Concluded at 4.30 P.M. You are requested to take the above information on record. Kindly acknowledge the receipt of the same. Thanking You,
Board Meeting - 22-Jul-2020 - -
PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2020 ,inter alia, to consider and approve Standalone and Consolidated Audited IND-AS compliant Financial Results along with Auditor Report for the quarter and year ended on 31st March, 2020 pursuant to regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director. Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) we wish to inform you that in the meeting of the Board of Directors of the Company held on Friday, 31st July, 2020 at its Registered Office, the Board inter alia has transacted the following business: 1. Approval of Audited Standalone and Consolidated Financial Results along with Auditor Report for the quarter and year ended 31st March, 2020 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Approved Half Yearly Standalone Statement of Assets and Liabilities for year ended 31st March, 2020. The Meeting was commenced at 4.00 p.m. and concluded at 6.30 p.m. (As Per BSE Announcement dated on 31.07.2020)
Board Meeting - 20-Jun-2020 - -
PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2020 ,inter alia, to consider and approve 1. To approve Standalone and Consolidated Audited IND-AS compliant Financial Results along with Auditor Report for the quarter and year ended on 31st March, 2020 pursuant to regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director. Parnax Lab Limited 30/06/2020 Audited Results(Cancelled) (As Per BSE Bulletin Dated on 25-06-2020)
Board Meeting - 06-Mar-2020 - -
PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/03/2020 ,inter alia, to consider and approve This is to inform you that, the meeting of the Board of Directors of the Company Parnax Lab Limited will be held on Monday, 16th March, 2020 at the registered office of the Company to transact the following business: 1. To approve re-appointment of Mr. Tirunillai Anantharaman (DIN: 07147028) as a Non-Executive Independent Director of the Company for second term of 5 consecutive years for the period starting from 1st April, 2020 to 31st March, 2025, subject to approval of the members in the ensuing Annual General Meeting. 2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including at least one Independent Director. Kindly acknowledge the receipt of the same. Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) we wish to inform you that in the meeting of the Board of Directors of the Company held on Monday,16th March, 2020 at its Registered Office, the Board inter alia has transacted the following business: 1. Approval of re-appointment of Mr. Tirunillai Anantharaman ( DIN: 07147028 ) as a non executive Independent director of the Company for second term of 5 consecutive years for the period starting from 31st March, 2020 to 30th March, 2025, subject to approval of the members in the ensuring Annual General Meeting. The Meeting was commenced at 4.00 p.m. and concluded at 5.00 p.m. Kindly take the same on your record. (As Per BSE Announcement dated on 16/03/2020)
Board Meeting - 03-Feb-2020 - -
PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2020 ,inter alia, to consider and approve standalone and Consolidated Un-audited IND- AS Compliant Financial Result along with Limited Review Report for the quarter ended 31st December, 2019 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Any other business with permission of chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director. Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) we wish to inform you that in the meeting of the Board of Directors of the Company held on Friday,14th February, 2020 at its Registered Office, the Board inter alia has transacted the following business: 1. Approval of Un-Audited Standalone & Consolidated Financial Results as submitted by statutory auditor of the Company for the quarter ended 31st December 2019. 2. Considered and took note of Limited Review Report for the quarter ended 31st December, 2019. The Meeting was commenced at 4.00 p.m. and concluded at 7.15 p.m. Kindly take the same on your record. (As Per BSE Announcement dated on 14.02.2020)